Showing 101 - 120 results of 11,943 for search '(( third ((((larger decrease) OR (a decrease))) OR (nn decrease)) ) OR ( data 1 decrease ))', query time: 0.58s Refine Results
  1. 101

    S1 Dataset - by Samnang Um (14990562)

    Published 2025
    “…<div><p>Diarrhea is a global public health problem that is the third leading cause of death in under five years, with an estimated 1.7 billion cases in 2023 and 1.8 million deaths from diarrhea diseases every year. …”
  2. 102
  3. 103
  4. 104
  5. 105

    Effects of GJE extract treatment decreased expression of NF-kB p65. by Natnicha Suttawong (22367172)

    Published 2025
    “…The percentage of positive staining for NF-kB p65 (E). Data are expressed as mean ± SD, error bars indicate standard deviation, n = 6/group. a: when compared to the control group. b: when compared to the NF group, <i><i>p</i></i> < 0.05 for both a and b.…”
  6. 106
  7. 107
  8. 108
  9. 109
  10. 110
  11. 111
  12. 112
  13. 113

    Table1_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.DOCX by J. Riera-Arnau (20431328)

    Published 2024
    “…In the sensitivity analysis, the A-level usage rate decreased to one-third and the B-level usage rate increased by 2–3 times. …”
  14. 114
  15. 115
  16. 116
  17. 117
  18. 118

    Data Sheet 1_Prehospital tranexamic acid decreases early mortality in trauma patients: a systematic review and meta-analysis.docx by Yi Li (1144)

    Published 2025
    “…Compared to the control group, the prehospital TXA group exhibited a significant reduction in 24-h mortality with an OR of 0.72 and a 95% CI of 0.54–0.94 (p = 0.02), while no statistically significant difference in the incidence of venous thromboembolism (VTE; OR: 1.14, 95% CI: 0.98–1.33, p = 0.09). No significant differences were observed in other outcomes, such as 28–30-day mortality, overall mortality, length of hospital stay, and the incidence of multiple organ failure (all p > 0.05).…”
  19. 119

    Data Sheet 1_Decreased brain-derived neurotrophic factor expression in chronic kidney disease: integrated clinical and experimental evidence.docx by Juan Chen (61123)

    Published 2025
    “…However, the evidence and regulatory mechanisms underlying decreased BDNF levels in CKD remain inconclusive.</p>Methods<p>This study systematically evaluated circulating BDNF alterations in CKD patients through a meta-analysis of clinical studies involving 1,549 participants, complemented by experimental validation in unilateral ureteral obstruction (UUO) mice and single-cell transcriptomic database analysis to investigate tissue-specific BDNF protein expression and regulatory patterns.…”
  20. 120